亚太地区定制抗体市场预测至 2028 年 - COVID-19 影响和按服务划分的区域分析(抗体开发、抗体生产和纯化以及抗体片段化和标签);类型(单克隆抗体、多克隆抗体和其他定制抗体);来源(小鼠、兔子等);研究领域(肿瘤学、免疫学、干细胞、传染病、神经生物学、心血管疾病等);最终用户(制药和生物技术公司、学术和研究机构以及合同研究组织)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 175    |    Report Code: TIPRE00023603    |    Category: Life Sciences

Asia Pacific Custom Antibody Market

市场介绍

可以在小鼠、大鼠或仓鼠中生成定制抗体,以满足任何宿主的要求。公司正在根据研究人员的要求提供各种抗体。市场上有各种定制抗体,包括多克隆和单克隆抗体、重组单克隆抗体、杂交瘤抗体、多克隆重组抗体等。此外,公司为抗体生产的所有类型和步骤提供完整的支持服务,从肽设计、合成、和载体蛋白缀合到动物免疫、血清收集或杂交瘤融合、滴度分析和最终抗体纯化。

因此,研究的高需求预计将在未来对定制抗体产生巨大需求预计将进一步推动定制抗体市场的发展。

亚太地区国家正面临着由于 COVID-19 发病率上升而带来的挑战。 COVID-19 大流行给世界许多国家的卫生系统带来了巨大压力。在大流行初期,许多亚太国家的检测能力有限且质量低下,导致 COVID-19 病例激增。然而,韩国、日本和新加坡等许多国家通过强有力的跟踪和测试,有效地控制了局势。此外,印度的病例数位居世界第二,仅次于美国。因此,新冠肺炎 (COVID-19) 造成了一场非同寻常的紧急情况,对供应链的影响尤其严重。供应链中断,以及对治疗 COVID 19 的有效诊断和治疗方法的巨大需求,使亚太地区的医疗保健研究行业处于危急境地。然而,许多市场参与者现在意识到了 COVID 19 抗体检测的重要性,预计这将在预测期内增加对定制抗体的需求。

 

 

市场概况与动态

亚太地区定制抗体市场预计将从2021年的8230万美元增长到2028年的1.748亿美元;预计 2021 年至 2028 年复合年增长率为 11.4%。抗体(包括单克隆和多克隆)在学术、研究和制药机构和组织中得到应用。使用这些抗体,研究所和组织开展多项药物和生物标志物开发以及其他治疗和临床诊断产品开发的研究和开发活动。定制抗体在研究中广泛受到青睐,以区分抗体产品。这些抗体经过不断评估,以提供安全、准确、高效且质量更高的产品。例如,2020年1月,世界卫生组织(WHO)称,中国和澳大利亚研究人员的合作团队发表了他们对病毒第一个基因组的研究。 SARS-CoV-2 对于研究至关重要,特别是在与其疫苗开发相关的研究中。截至2020年5月13日,该病毒已被测序超过3000次,以使其基因图谱免费提供给全球研究人员,这产生了对定制抗体的巨大需求。中小企业的研发投资和活动成倍增加。此类投资增加了对定制抗体的需求。

 

关键细分市场

从服务来看,抗体开发细分市场占据了2020年亚太定制抗体市场的最大份额。从类型来看,单克隆抗体细分市场占据了2020年亚太定制抗体市场的最大份额。从来源来看,小鼠细分市场在2020年亚太定制抗体市场中占据最大份额。从研究领域来看,肿瘤领域在2020年定制抗体市场中占有较大的市场份额。从最终用户来看, 2020年,制药和生物技术公司细分市场在定制抗体市场中占有更大的市场份额。

 

主要来源和上市公司

在准备本亚太地区定制抗体市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Thermo Fisher Scientific Inc.、Bio-Rad Laboratories Inc.、Merck KGAA、Abcam、Genscript、Agilent Technologies, Inc. 和 Cell Signaling Technology, Inc.

 

购买报告的理由

  • 了解亚太地区定制抗体市场格局并确定最有可能保证丰厚回报的细分市场
  • 了解亚太定制抗体市场不断变化的竞争格局,保持领先地位
  • 通过识别细分市场,有效规划亚太定制抗体市场的并购和合作交易最有前途的可能销售
  • 通过对亚太定制抗体市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获得各个市场的市场收入预测2021-2028 年亚太地区细分市场

 

亚太定制抗体市场细分

按服务

  • 抗体开发
  • < span>抗体生产和纯化
  • 抗体片段化和标记

 

类型

  • 单克隆抗体
  • 多克隆抗体
  • 其他定制抗体

 < /span>

按来源

  • 小鼠
  • 兔子
  • 其他

 

按研究领域

  • 肿瘤学
  • 免疫学
  • 干细胞
  • 传染病
  • 神经生物学
  • < li>心血管疾病
  • 其他

 < /strong>

最终用户

  • 制药和生物技术公司
  • 学术和研究机构
  • 合同研究组织

 

按国家/地区

  • 亚太地区
    • 中国
    • < li>日本
    • 印度
    • 韩国
    • 澳大利亚
    • 亚太地区其他地区

 

< p>

提及的公司

  1. Thermo Fisher Scientific Inc.
  2. Bio-Rad Laboratories Inc.
  3. Merck KGAA
  4. Merck KGAA
  5. Bio-Rad Laboratories Inc.
  6. Merck KGAA
  7. li>
  8. Abcam
  9. 金斯瑞
  10. 安捷伦科技公司
  11. Cell Signaling Technology, Inc.

 

 

Asia Pacific Custom Antibody Strategic Insights

Strategic insights for Asia Pacific Custom Antibody involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-custom-antibody-market-strategic-framework.webp
Get more information on this report

Asia Pacific Custom Antibody Report Scope

Report Attribute Details
Market size in 2021 US$ 82.3 Million
Market Size by 2028 US$ 174.8 Million
Global CAGR (2021 - 2028) 11.4%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 服务
  • 抗体开发
  • 抗体生产和纯化
  • 抗体片段化和标记
By 类型
  • 单克隆抗体
  • 多克隆抗体
  • 其他定制抗体
By 来源
  • 小鼠
  • 兔子
By 研究领域
  • 肿瘤学
  • 免疫学
  • 干细胞
  • 传染病
  • 神经生物学
  • 心血管疾病
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGAA
  • Abcam
  • Genscript
  • Agilent Technologies, Inc.
  • Cell Signaling Technology, Inc.
  • Get more information on this report

    Asia Pacific Custom Antibody Regional Insights

    The regional scope of Asia Pacific Custom Antibody refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-custom-antibody-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Custom Antibody Market

    1. Thermo Fisher Scientific Inc.
    2. Bio-Rad Laboratories Inc.
    3. Merck KGAA
    4. Abcam
    5. Genscript
    6. Agilent Technologies, Inc.
    7. Cell Signaling Technology, Inc.
    Frequently Asked Questions
    How big is the Asia Pacific Custom Antibody Market?

    The Asia Pacific Custom Antibody Market is valued at US$ 82.3 Million in 2021, it is projected to reach US$ 174.8 Million by 2028.

    What is the CAGR for Asia Pacific Custom Antibody Market by (2021 - 2028)?

    As per our report Asia Pacific Custom Antibody Market, the market size is valued at US$ 82.3 Million in 2021, projecting it to reach US$ 174.8 Million by 2028. This translates to a CAGR of approximately 11.4% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Custom Antibody Market report typically cover these key segments-

  • 服务 (抗体开发, 抗体生产和纯化, 抗体片段化和标记)
  • 类型 (单克隆抗体, 多克隆抗体, 其他定制抗体)
  • 来源 (小鼠, 兔子)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Custom Antibody Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Custom Antibody Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Custom Antibody Market?

    The Asia Pacific Custom Antibody Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGAA
  • Abcam
  • Genscript
  • Agilent Technologies, Inc.
  • Cell Signaling Technology, Inc.
  • Who should buy this report?

    The Asia Pacific Custom Antibody Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Custom Antibody Market value chain can benefit from the information contained in a comprehensive market report.